Deoxynivalenol induces global DNA hypomethylation by modulating the expression of miR-29b and DNA methylation regulators in HepG2 cells.

Food Chem Toxicol

Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, 4041, South Africa. Electronic address:

Published: July 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Deoxynivalenol (DON) is a globally distributed mycotoxin that contaminates agricultural foods. Previous studies have reported high concentrations of DON in staple foods as well as its associated toxic effects; however, there are limited studies on DNA methylation. Therefore, we investigated the effect of DON on global DNA methylation as well as the possible mechanism of DNA methylation changes by miR-29b and DNA methylation regulators in human hepatocellular carcinoma (HepG2) cells. HepG2 cells were exposed to 5, 10, and 26.17 μM of DON for 72 h. Global DNA methylation was determined using ELISA, whilst DNMT1, DNMT3a, DNMT3b, MBD2, TET1-3, and miR-29b expressions were measured using qPCR. The protein expression of DNMT1, DNMT3a, DNMT3b, and MBD2 was determined by Western blotting. At concentrations of 10 and 26.17 μM, DON induced global DNA hypomethylation. DON upregulated DNMT1 and downregulated DNMT3b; however, DNMT3a was only significantly downregulated by 5 μM DON. The protein expression of DNMT1 was upregulated and DNMT3b was downregulated at all DON concentrations, whereas DNMT3a was downregulated by 10 and 26.17 μM DON. DON upregulated MBD2 mRNA expression but downregulated its protein expression. TET2 and TET3 were upregulated, while TET1 was downregulated. miR-29b expression was significantly upregulated by 10 and 26.17 μM DON. Together, these results indicate that DON induced global DNA hypomethylation in HepG2 cells by altering miR-29b expression as well as DNMTs, MBD2, and TET expression levels, and provide insight into the potential of DON, as a DNA hypomethylation inducer, to cause genomic instability and cancer initiation and progression.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.fct.2025.115674DOI Listing

Publication Analysis

Top Keywords

dna methylation
24
global dna
20
dna hypomethylation
16
hepg2 cells
16
2617 μm don
16
don
13
protein expression
12
dna
10
expression
8
mir-29b dna
8

Similar Publications

The effect of non-functionalized polystyrene nanoparticles (PS-NPs) with diameters of 29, 44, and 72 nm on plasmid DNA integrity and the expression of genes involved in the architecture of chromatin was investigated in human peripheral blood mononuclear cells (PBMCs). The cells were incubated with PS-NPs at concentrations ranging from 0.001 to 100 µg/mL for 24 hours.

View Article and Find Full Text PDF

PRMT1-Mediated PARP1 Methylation Drives Lung Metastasis and Chemoresistance via P65 Activation in Triple-Negative Breast Cancer.

Research (Wash D C)

September 2025

State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.

Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype, characterized by a high propensity for metastasis, poor prognosis, and limited treatment options. Research has demonstrated a substantial correlation between the expression of protein arginine N-methyltransferase 1 (PRMT1) and enhanced proliferation, metastasis, and poor outcomes in TNBC. However, the specific role of PRMT1 in lung metastasis and chemoresistance remains unclear.

View Article and Find Full Text PDF

Unraveling epigenetic drivers of immune evasion in gliomas: mechanisms and therapeutic implications.

Front Immunol

September 2025

Precision Pharmacy and Drug Development Center, Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.

Gliomas are the most common primary malignant tumors of the central nervous system (CNS), and despite progress in molecular diagnostics and targeted therapies, their prognosis remains poor. In recent years, immunotherapy has emerged as a promising treatment modality in cancer therapy. However, the inevitable immune evasion by tumor cells is a key barrier affecting therapeutic efficacy.

View Article and Find Full Text PDF

Background: The objective of this study is to investigate the predictive role of O6-methylguanine-DNA methyltransferase (MGMT) and isocitrate dehydrogenase (IDH) status on the efficacy of bevacizumab (BEV) in high-grade glioma (HGG), while excluding the interference of chemotherapy agents.

Methods: A retrospective, single-center analysis was conducted on 103 patients with HGG who received BEV treatment. The enrolled patients were grouped based on their different biomarker statuses.

View Article and Find Full Text PDF

Immediate and durable effects of maternal tobacco consumption on placental DNA methylation: a replication and discovery study.

Environ Epigenet

May 2025

Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Institut pour l'Avancée des Biosciences (IAB), Team of Environmental Epidemiology Applied to Development and Respiratory Health, 38000 Grenoble, France.

An increasing number of epigenome-wide association studies report tobacco smoking-associated DNA methylation levels. However, comprehensive replication studies remain scarce, particularly in placenta, despite their crucial interest in such a large-scale context. Using DNA methylation data from the EPIC array of 341 new placentas (85 smokers, 219 non-smokers, and 37 former smokers) from the EDEN cohort, we used a candidate approach to replicate maternal smoking-associated CpGs and regions previously identified using the 450K array, and an exploratory approach to discover new associations within EPIC-specific CpGs.

View Article and Find Full Text PDF